ARS Pharmaceuticals Inc (SPRY) PT Raised to $30 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Josh Schimmer raised the price target on ARS Pharmaceuticals Inc (NASDAQ: SPRY) to $30.00 (from $12.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
